Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan / Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S.. - In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. - ISSN 1083-8791. - 16:(2010). [10.1016/j.bbmt.2010.02.011]

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

PANE, FABRIZIO;
2010

2010
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan / Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S.. - In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. - ISSN 1083-8791. - 16:(2010). [10.1016/j.bbmt.2010.02.011]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/574359
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 8
social impact